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Abstract
Regeneration of blood vessels in ischemic neuronal tissue is critical to reduce tissue damage in
diseases. In proliferative retinopathy, initial vessel loss leads to retinal ischemia, which can induce
either regrowth of vessels to restore normal metabolism and minimize damage, or progress to
hypoxia-induced sight-threatening pathologic vaso-proliferation. It is not well understood how
retinal neurons mediate regeneration of vascular growth in response to ischemic insults. In this
study we aim to investigate the potential role of Sirtuin 1 (Sirt1), a metabolically-regulated protein
deacetylase, in mediating the response of ischemic neurons to regulate vascular regrowth in a
mouse model of oxygen-induced ischemic retinopathy (OIR). We found that Sirt1 is highly
induced in the avascular ischemic retina in OIR. Conditional depletion of neuronal Sirt1 leads to
significantly decreased retinal vascular regeneration into the avascular zone and increased
hypoxia-induced pathologic vascular growth. This effect is likely independent of PGC-1α, a
known Sirt1 target, as absence of PGC-1α in knockout mice does not impact vascular growth in
retinopathy. We found that neuronal Sirt1 controls vascular regrowth in part through modulating
deacetylation and stability of hypoxia-induced factor 1α and 2α, and thereby modulating
expression of angiogenic factors. These results indicate that ischemic neurons induce Sirt1 to
promote revascularization into ischemic neuronal areas, suggesting a novel role of neuronal Sirt1
in mediating vascular regeneration in ischemic conditions, with potential implications beyond
retinopathy.
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Ischemic proliferative retinopathies, including retinopathy of prematurity (ROP) and
diabetic retinopathy (DR), are leading causes of blindness [1]. Retinopathy occurs in two
phases, with a first phase of vessel loss due to prematurity or diabetes, and a second phase of
hypoxia-induced abnormal proliferation of pathologic vessels. The morphology of
pathologic neovascularization is distinctly different from normal vasculature with increased
leakage and associated retinal detachment and blindness. Physiologic revascularization also
occurs in the second phase of retinopathy, which repairs initial vessel loss in the ischemic
avascular zone to restore finely branched normal vasculature. Current interventions focus on
suppression of the late phase proliferative neovessels through surgical ablation of hypoxic
retina or by anti-VEGF (vascular endothelial growth factor) therapy, which also can inhibit
physiologic revascularization into the avascular zone. However, promoting normal
revascularization to repair ischemic neuronal tissue will prevent the ischemic and metabolic
stimuli triggering blinding neovessel proliferation [2].
To achieve the goal of preventing neovascularization, it is essential to understand how
ischemic neurons respond to vessel loss and metabolic stress to mediate revascularization.
Emerging evidence demonstrates a role of neuronal influence in the process of guiding
vascular growth in retinopathy [2, 3]. Not only neuronal guidance growth factors but also
neuron-derived energy dependent metabolites are implicated in influencing vascular
development in retinopathy [2, 4–6], suggesting that the metabolic state of retinal neurons
play a significant role in determining vascular response in retinopathy. We hypothesized that
Sirtuin1 (Sirt1), a metabolic and nutrient sensitive regulator [7], is involved in this ischemia-
induced reparative angiogenic process.
Sirt1 is a NAD+ dependent protein deacetylase activated under stress condition to regulate
cell cycles and longevity [8]. Increased levels of Sirt1 in neurons protect against several
neuronal degenerative diseases such as Alzheimer’s [9] and Huntington’s disease [10], both
of which are precipitated by neuronal ischemia. Deletion of Sirt1 in neurons also affects
normal cognitive function [11]. In addition to neuronal expression, Sirt1 in vascular
endothelial cells can also directly regulate endothelial cell growth [12, 13]. Little is known,
however, about the potential role of neuronal Sirt1 in neurovascular cross-talk in ischemic
conditions to direct blood vessel growth to revascularize and restore ischemic tissue, which
is the focus of this study.
Here we used a mouse model of oxygen-induced ischemic retinopathy (OIR) to explore the
potential role of neuronal Sirt1 in mediating retinal revascularization. OIR is characterized
by vessel loss followed by vascular regrowth and hypoxia-induced neovascularization [14].
This is a well-established animal model of ROP and also mimics some aspects of
neovascularization of proliferative DR in humans [15]. Mice with neuronal-specific
conditional depletion of Sirt1 were generated and analyzed in this model. We found
significant upregulation of Sirt1 in the retinal ganglion cell layer of avascular retinal area in
OIR. Neuronal depletion of Sirt1 significantly dampened retinal vascular regrowth in OIR,
associated with aggravated pathologic neovascularization. These effects are likely mediated
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These studies were approved by the Children’s Hospital Boston Animal Care and Use
Committee. Sirt1flox|flox mice were previously described [16]. Nestin-Cre mice (stock#
003771) and PGC-1α−/− (stock# 008597) were obtained from Jackson Laboratory. Both
Sirt1 cKO mice and PGC-1α−/− mice were backcrossed to C57BL/6 mice for at least 9
generations.
Oxygen-induced retinopathy, retina dissection and quantification of vaso-obliteration and
vaso-proliferation
To induce oxygen-induced retinopathy (OIR), neonatal mice were exposed to 75 % oxygen
from P7 to P12 [14]. Eyes were dissected at various ages and retinal blood vessels stained
with fluoresceinated Isolectin B4. Quantification of retinal vasculature was carried out as
described previously by using Adobe Photoshop or Image J [17–19], with specifics detailed
in supplemental methods.
Cell culture
The rat ganglion cell line, RGC-5, was a kind gift from N. Agarwal. These cells were
differentiated by incubation with 1 μM staurosporine for 12 h, which maintains them in a
post-mitotic neuronal state [20]. Cells were treated with Sirt1 inhibitor Ex527 (1 or 10 mM)
or DMSO control for 24 h under hypoxia (2 % O2) and cell lysates were isolated for gene
expression, immunoprecipitation or Western blots. For conditioned medium, Ex527-
containing medium was removed and replaced with fresh DMEM (Invitrogen) conditioned
by stimulated RGC-5 cells for 24 h, at which point the medium was collected, filtered and
subsequently used to culture aortic ring explants and for the Epo ELISA assay.
Aortic ring explant
Aortae from C57Bl/6J mice were cut into 1-mm-thick rings and placed in growth factor–
reduced Matrigel (BD Biosciences) in 24-well tissue culture plates and cultured for 2 days in
EBM-2 medium (Clonetics) [21], replaced by conditioned medium from RGC-5 cell culture
treated previously with Sirt1 inhibitor Ex527 for 72 h. Images of individual explants were
taken and the microvascular sprouting area was quantified by measuring the area covered by
outgrowth of the aortic ring with Adobe Photoshop. Results are expressed as mean ± SEM.
Statistical analysis
Results were presented as mean ± SEM and were analyzed using a 2-tailed Student t test. p
values ≤0.05 is considered statistically significant.
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Sirt1 is upregulated in avascular neurons in OIR
To induce retinopathy, mouse pups with nursing mothers were exposed to 75 % oxygen
from postnatal day (P) 7 to day 12, and returned to room air until P17 [14] (Fig. 1a). Central
retinal vessel loss is induced during oxygen exposure starting from 8 h after oxygen
treatment, and continuing to P12. After returning to room air, revascularization of avascular
central retinal area occurs, associated with pathologic neo-vascularization at the border
between avascular and vascular zones [18, 22]. We found that Sirt1 mRNA expression is
consistently upregulated in retinas with OIR (Fig. 1a). The upregulation of Sirt1 protein is
confirmed with quantification of Western blots (Fig. 1b). Next, we used micro-dissection to
separate the central avascular zones and the peripheral vascularized regions of OIR-exposed
retinas at P8 and P12 (Fig. 1c). Absence of endothelial cell marker VE-cadherin mRNA
expression confirmed lack of blood vessels in the samples from the central areas (Fig. 1c).
Importantly, Sirt1 mRNA levels are significantly induced in the central avascular zone of
the retinas compared to the peripheral vascularized regions (Fig. 1c), suggesting stress-
induced upregulated of Sirt1 in retinal neurons from the avascular region. The upregulation
of Sirt1 in the central avascular region in OIR is confirmed at protein levels at P12 in micro-
dissected samples, compared to peripheral samples (Fig. 1d). In addition, Sirt1 antibody
staining shows marked enrichment of staining in the nuclear region of the retinal ganglion
cell (RGC) layer (Fig. 1e), suggesting that in OIR, Sirt1 is upregulated in retinal neurons in
the avascular region of RGC layer in response to retinal ischemia.
Depletion of neuronal Sirt1 dampens vascular regrowth in retinopathy
Since systemic Sirt1−/− mice survive infrequently after birth [16], we generated neuronal
specific conditional knockout of Sirt1 (Sirt1 cKO) by crossing floxed Sirt1 knockout mice
(Sirt1flox|flox) [16] with Nestin-Cre mice expressing Cre recombinase under neuronal specific
nestin promoter. Sirt1 cKO mice are live, fertile and grossly normal with significantly
decreased levels of Sirt1 protein in the retina compared to littermate control Sirt1flox|flox
mice (Fig. 2a). With OIR, Sirt1 cKO retinas show significantly increased levels of vaso-
obliteration (VO) at P17 compared with litter mate Sirt1flox|flox controls (22.1 ± 0.9 % of
total retinal area in Sirt1 cKO versus 18.3 ± 0.8 % of total retinal area in controls, n = 18–20
per group, p = 0.003, Fig. 2b, c), and are associated with significantly increased levels of
pathologic neovascularization (11.0 ± 0.5 % of total retinal area in Sirt1 cKO versus 8.8 ±
0.4 % of total retinal area in controls, p = 0.009, Fig. 2b, c). Vaso-obliteration at P9 and P12
during oxygen exposure is comparable between Sirt1 cKO and Sirt1flox|flox retinas (Fig.
S1a), suggesting that the increased vaso-obliteration in Sirt1 cKO retinas at P17 results from
dampened revascularization of the avascular retina after returning to room air at P12. There
is a ~20 % reduction of revascularization and hence a ~20 % increase in VO areas in Sirt1
cKO retina compared to controls at P17. This marked inhibition of revascularization is
associated with aggravated neovascularization. Retinal vascular growth during normal
development is not affected in Sirt1 cKO retina (Fig. S1b), indicating that neuronal Sirt1
acts exclusively as a stress response mechanism in diseased retinal conditions but does not
impact normal angiogenesis. In addition, we confirmed that the expression of Cre
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recombinase alone in retinal neurons without a floxed gene (Nes–Cre) in mice does not
affect retinopathy outcome compared to littermate wild type (WT) controls (Fig. S2a, b).
The effect of neuronal Sirt1 on retinal vascular growth in OIR is likely independent of
PGC1α
Loss of Sirt1 in retinal neurons significantly suppresses retinal levels of PGC-1α
(peroxisome proliferator-activated receptor gamma coactivator-1 alpha), a known Sirt1
target important in tissue metabolism [23, 24], and a regulator of vascular endothelial
growth factor (Vegf) [25] (Fig. 3a). However, deletion of PGC-1α in KO mice (PGC-1α−/−)
does not significantly impact either vaso-obliteration or pathologic neovascularization in
OIR compared to WT littermate controls at P17 (n = 10–11 per group, p = 0.80 for VO, p =
0.30 for NV, Fig. 3b, c), although there is a trend of slightly decreased neovascularization in
OIR, as reported in a recent study with a smaller number of samples [26]. These data
suggest that the noted effects on retinal vasculature secondary to neuronal specific knockout
of Sirt1 in OIR is likely mediated by factors other than PGC-1α. We found deletion of
PGC-1α also does not affect developmental angiogenesis in the retina at P5 (Fig. S3). It is
important to note that approximately half of PGC-1α−/− pups die in the early postnatal
period and the surviving PGC-1α−/− mice show decreased body weight compared to WT or
heterozygous littermates [27], which we have found impacts retinopathy outcomes [28].
Therefore severely lethargic PGC-1α−/− pups or those with low body weight were excluded
in our study [28].
Decreased levels of angiogenic factors and hypoxia induced factor (HIF) in Sirt1 cKO
retinas
Next, we assessed in Sirt1 cKO retinas the levels of Vegf and erythropoietin (Epo), two
hypoxia responsive genes implicated in regulating vascular regeneration in proliferative
retinopathy [29, 30]. Both Vegf and Epo are significantly down-regulated in Sirt1 cKO retina
exposed to oxygen-induced retinopathy compared to Sirt1flox|flox controls (Fig. 3d). This
decrease of Vegf and Epo expression is associated with significantly decreased protein levels
of hypoxia-induced factor (HIF)1α and 2α in the Sirt1 cKO retinas compared to Sirt1flox|flox
controls (Fig. 3e). These results suggest that endogenous Sirt1 upregulation in the ischemic
neurons may thereby potentiate the hypoxia/nutrient deficiency response to promote
vascular regeneration into avascular areas in OIR. Lack of growth factors such as Vegf or
Epo in Sirt1 cko retinas may directly contribute to the dampen revascularization into
avascular zones in OIR, resulting a secondary aggravated pathologic neovascular (NV)
response, which is dependent not only on availability of angiogenic factors but also
inflammatory response that is exacerbated in the lack of vascular regrowth [31, 32].
Sirt1 mediates acetylation of hypoxia-induced factors (HIF) in RGC-5 cells to regulates
vascular growth
Since Sirt1 is highly enriched in the retinal ganglion cell layer in OIR retinas (Fig. 1e), we
used an in vitro cell culture model (RGC-5) of retinal ganglion cell that upon differentiation
exhibits characteristic neuronal morphology and the RGC marker β-III-tubulin (Fig. 4a).
RGC-5 cells treated with Ex527, a Sirt1 specific inhibitor, showed suppression of Sirt1
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deacetylase activity, as evidenced by increased levels of protein acetylation detected by an
acetyl-lysine antibody (Fig. 4b). The strong staining around 15–20kd are likely isoforms of
histones, which are major endogenous substrates of Sirt1 [7].
RGC-5 cell lysate treated with Sirt1 inhibitor Ex527 showed increased acetylation of both
HIF1α and HIF2α, detected by immunoprecipitation with antibodies against acetyl-lysine
(Fig. 4c). This post-translational modification of HIF1α and HIF2α can promote their
degradation [33, 34], and consequently results in significant inhibition of HIF-dependent
gene Epo expression, as well as significantly decreased Epo protein levels (Fig. 4d). VEGF
mRNA and protein levels in RGC-5, however, do not show a significant difference with
treatment of Sirt1 inhibitor Ex527 (Fig. S4a, b). This lack of change, compared with in vivo
suppression of VEGF in Sirt1 cKO retinas, likely reflects different cellular sources of VEGF
production in vivo, including glial cells and other retinal neuronal cells, which are not
accounted for in RGC-5 cell culture.
Next conditioned medium from RGC-5 cultures treated with Ex527 were collected and
applied to aortic ring explants to evaluate if Sirt1 inhibition in RGC-5 culture can influence
vascular growth in vitro. This medium significantly suppressed vascular sprouting of aortic
rings compared to conditioned medium from vehicle-treated RGC-5s (Fig. 4e). These results
suggest that Sirt1 in RGC-5 regulates HIF acetylation and degradation to influence
expression of growth factors including Epo, which may in turn mediate vascular growth.
Our results on Sirt1-dependent regulation of HIFs are in agreement with previous studies
showing that Sirt1 is essential for HIF1α and HIF2α accumulation and expression of their
target genes in liver and tumor cells in response to hypoxia [33, 34].
Altered inflammatory response and anti-angiogenic factors in Sirt1 cKO retinas
While our data demonstrate that Sirt1 mediates HIF acetylation and pro-angiogenic growth
factors, these factors might not be the only ones changed in the absence of neuronal Sirt1.
Next we analyzed expression of inflammatory cytokines which also impact vascular
response in retinopathy. We identified in OIR significantly increased expression of pro-
inflammatory cytokines TNFα, IL-1β and IL-6 in Sirt1 cKO retinas compared to controls at
P12, as well as significant inhibition of SOCS3 (suppressor of cytokine signaling 3), which
is a negative regulator of cytokine signaling with anti-inflammatory functions (Fig. 4f).
These inflammatory factors are not significantly altered in RGC-5 cell culture with Sirt1
inhibition (Fig. S4c), since ganglion cells are likely not the major source of inflammatory
influences in Sirt1 cKO retinas. These results indicate an enhanced inflammatory response
in Sirt1 cKO retinas secondary to neuronal loss of Sirt1, which may also contribute in part to
the decreased vaso-regeneration and precipitated neovascularization.
In addition, anti-angiogenic factors were analyzed in the Sirt1 cKO retinas compared to
control floxed retinas in OIR. Significantly increased expression of thrombospondin-1
(TSP-1), TSP-2, TIMP-1 and PEDF were observed in Sirt1 cKO retina compared to control
retinas at P12 in OIR, suggesting that upregulation of these anti-angiogenic factors may
suppress the physiologic revascularization into the avascular zone which starts at P12 (Fig.
4g). These factors are not significantly changed at P15 and P17 in OIR (data not shown),
suggesting that they likely do not contribute directly to pathologic neovascularization which
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usually occurs starting at P15. RGC-5 cell culture with Sirt1 inhibition does not show an
upregulation of anti-angiogenic factors as is seen in Sirt1 cKO retinas (Fig. S4d), likely
reflecting a retinal cellular source of these factors other than ganglion cells, and/or a lack of
critical complex cellular interactions in cell culture conditions. Together these data suggest
increased inflammatory response and decreased anti-angiogenic factors in Sirt1 cKO retinas
may also contribute in part to the observed decrease in vaso-regeneration.
In summary, our study suggests a novel role of neuronal Sirt1 in mediating vascular growth
in a mouse model of oxygen-induced proliferative retinopathy. Ischemic/nutrient deprived
retinal neurons in avascular region may induce Sirt1 under metabolically stressed conditions
to influence physiologic revascularization of ischemic areas via modulation of HIF signaling
and secretion of pro-angiogenic and neuro-protective factors, such as Vegf and Epo, as well
as through an altered inflammatory response and expression of anti-angiogenic factors.
Although high levels of Vegf and Epo levels directly contribute to the proliferative stage of
retinopathy, suppression of both factors below normal levels may also inhibit the
physiologic revascularization process that is essential to repair vaso-obliterated retina and
restore normal vessels. In the absence of neuronal Sirt1, disruption of these Sirt1 mediated
responses may therefore dampen physiologic vascular regeneration and result in secondary
exacerbation of subsequent pathologic vaso-proliferation. Our findings may also be relevant
for other neurovascular ischemic diseases, such as stroke, in which regeneration of normal
vasculature in ischemic neuronal tissue is critical to prevent tissue injury and promote tissue
repair.
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Sirt1 is induced in avascular retina in a mouse model of oxygen-induced retinopathy (OIR). a Sirt1 mRNA expression is
significantly upregulated in a mouse model of oxygen-induced retinopathy, in which neonatal pups are exposed to 75 % oxygen
from postnatal day (P) 7 to P12. b Sirt1 protein levels are upregulated in OIR retinas compared to normoxic controls (Norm) at
P8. c At P12 in OIR, retinal vasculature is visualized with lectin staining (red) showing central avascular zone and peripheral
vascular zones (arrows), which were separated by micro-dissection. Sirt1 and VE-cadherin mRNA expression levels were
quantified with RT-qPCR in peripheral vascular versus central avascular samples isolated at P8 and P12 in OIR. Central
avascular retina samples show a lack of vascular endothelial cell marker VE-cadherin, confirming absence of vessels. Sirt1 is
significantly up-regulated in central avascular retinal samples compared to samples from peripheral vascular region. d Western
blot with Sirt1 antibody shows upregulated Sirt1 protein levels in samples isolated from central avascular regions of retinas in
OIR compared with peripheral vascular regions at P12. In room air control retinas (Norm) not exposed to OIR, Sirt1 levels are
lowered in the central region (C) compared to peripheral retinal region (P). e Immunohistochemistry staining of retinal cross
sections from P17 OIR mouse or room air control shows increased staining of Sirt1 antibody (green) in the retinal ganglion cell
layer (arrows), with enrichment in the cellular nucleus region visualized by double staining of DAPI (blue). ONL outer nuclear
layer, INL inner nuclear layer, RGC retinal ganglion cell layer. *p ≤ 0.05. (Color figure online)
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Depletion of neuronal Sirt1 decreases retinal revascularization in oxygen-induced retinopathy and consequently precipitates
pathologic neovascularization. a Western blots show that Sirt1 protein levels are significantly decreased in the retina of neuronal
specific conditional Sirt1 knockout mice (Sirt1 cKO) compared to littermate control mice (Sirt1flox|flox). b Representative images
of retinal vasculature from P17 Sirt1 cKO mice and littermate control Sirt1flox|flox mice with induced retinopathy (OIR). Blood
vessels were stained with lectin (red) with areas of vaso-obliteration highlighted by white line. Quantification of retinopathy in
Sirt1 cKO and control retina with OIR shows significantly increased levels of vaso-obliteration (absence of red) and pathologic
neovascularization (bright red) (n = 18–20 per group). **p ≤ 0.01. (Color figure online)
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Sirt1 regulation of vascular regrowth in retinopathy is likely mediated via regulation of hypoxia growth factors (HIF) 1α and
2α, other than PGC-1α. a At P12, 15, and 17 in OIR, depletion of neuronal Sirt1 results in significantly decreased mRNA levels
of Sirt1 and PGC-1a in the retinas compared to littermate Sirt1flox|flox controls. *p ≤ 0.05. b PGC-1a−/− mice do not show
significant differences in vaso-obliteration (outlined in white) and pathologic neovascularization in OIR at P17 compared to
littermate WT controls (n = 10–11 per group, n.s. not significant). d OIR exposed Sirt1 cKO retinas show significantly
decreased mRNA levels of angiogenic factors Vegf and Epo in the retinas compared to littermate Sirt1flox|flox controls. *p ≤ 0.05.
e Western blot with Sirt1 antibody shows decreased levels of HIF1α and 2α protein in Sirt1 cKO retinas compared to littermate
Sirt1flox|flox control retinas
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Sirt1 regulates acetylation of HIF1α and 2α, and expression of Epo in RGC-5 culture. a RGC-5 cells differentiated after
incubation with staurosporine show dendrites and axons (arrows) characteristic of neurons. RGC-5 cells also show staining with
antibody against βIII-tubulin (green), a RGC marker. b Incubation of RGC-5 cells with Ex527, a specific Sirt1 inhibitor, results
in increased levels of protein acetylation detected by an acetyl-lysine antibody. c Inhibition of Sirt1 with Ex527 in RGC-5
culture increased protein acetylation of HIF1α and HIF2α, detected by immunoprecipitation with acetyl-lysine antibody and
followed by Western blots against HIF1α or HIF2α. d Ex527 treatment of RGC-5 cells leads to decreased expression level of
Epo mRNA measured by RT-qPCR, and decreased Epo protein level measured by ELISA assay. e Aortic ring explants cultured
with conditioned medium from RGC-5 culture treated with Sirt1 inhibitor Ex527 shows significantly decreased levels of
vascular growth compared with RGC-5 medium treated with vehicle control (vascular sprouts outlined in white, n = 6–10 per
group). f Depletion of Sirt1 in neuronal retina leads to increased mRNA expression of inflammatory cytokines TNFα, IL-1β,
IL-6 and decreased mRNA level of SOCS3 at P12 in OIR. g Depletion of Sirt1 in neuronal retinal results in increased mRNA
expression of anti-angiogenic factors TSP-1, TSP-2, TIMP-1 and PEDF at P12 in OIR. *p ≤ 0.05; **p ≤ 0.01. (Color figure
online)
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